Over the last two decades, there has been a surge of opioid-related overdose deaths resulting in a myriad of state policy responses. Researchers have evaluated the effectiveness of such policies using a wide-range of statistical models, each of which requires multiple design choices that can...

Over the last two decades, there has been a surge of opioid-related overdose deaths resulting in a myriad of state policy responses. Researchers have evaluated the effectiveness of such policies using a wide-range of statistical models, each of which requires multiple design choices that can...

Many medical marijuana patients report using marijuana to alleviate chronic pain from musculoskeletal problems and other sources. If marijuana is used as a substitute for powerful and addictive pain relievers in medical marijuana states, a potential overlooked positive impact of medical...

Overdose deaths from prescription opioid pain relievers nearly quadrupled between 1999 and 2010, making this the worst drug overdose epidemic in U.S. history. In response, numerous supply-side interventions have aimed to limit access to opioids. However, these supply disruptions may have the...

Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality. State efforts to reduce overdose deaths by removing barriers to naloxone have recently focused on pharmacy channels, but the specifics of these laws and the contexts in which...

A large concern in U.S. opioid policy is whether supply side controls are effective at reducing the quantity of opioids prescribed, without harmful substitution. An unstudied way that policy targeted a major opioid through the federal Controlled Substance Act (CSA) was the August 2014 scheduling...